{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T11:33:54Z","timestamp":1746617634708},"reference-count":9,"publisher":"FapUNIFESP (SciELO)","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Sa\u00fade P\u00fablica"],"published-print":{"date-parts":[[2015]]},"abstract":"<jats:p>The Brazilian National Regulatory Agency for Private Health Insurance and Plans has recently published a technical note defining the criteria for the coverage of genetic testing to diagnose hereditary cancer. In this study we show the case of a patient with a breast lesion and an extensive history of cancer referred to a private service of genetic counseling. The patient met both criteria for hereditary breast and colorectal cancer syndrome screening. Her private insurance denied coverage for genetic testing because she lacks current or previous cancer diagnosis. After she appealed by lawsuit, the court was favorable and the test was performed using next-generation sequencing. A deletion of MLH1 exon 8 was found. We highlight the importance to offer genetic testing using multigene analysis for noncancer patients.<\/jats:p>","DOI":"10.1590\/s0034-8910.2015049005988","type":"journal-article","created":{"date-parts":[[2015,10,10]],"date-time":"2015-10-10T21:17:38Z","timestamp":1444511858000},"source":"Crossref","is-referenced-by-count":2,"title":["The importance to update the guidelines for the use of genetic testing in noncancer patients in Brazil"],"prefix":"10.1590","volume":"49","author":[{"given":"Tirzah Braz Petta","family":"Lajus","sequence":"first","affiliation":[{"name":"Liga Contra o C\u00e2ncer,  Brasil; Universidade Federal do Rio Grande do Norte,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0004.2008.01125.x","article-title":"Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations","volume":"75","author":"Barrow E","year":"2009","journal-title":"Clin Genet"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T","article-title":"Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies","volume":"56","author":"Lynch HT","year":"1985","journal-title":"Cancer"},{"issue":"11","key":"ref3","first-page":"801","article-title":"Genetic susceptibility to non-polyposis colorectal cancer","volume":"36","author":"Lynch HT","year":"1999","journal-title":"J Med Genet"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/1097-0142(19910901)68:5<1109::AID-CNCR2820680535>3.0.CO;2-S","article-title":"Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer)","volume":"68","author":"Mecklin JP","year":"1991","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger F","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/jmg.2010.077677","article-title":"Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers","volume":"47","author":"Sjursen W","year":"2010","journal-title":"J Med Genet"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar A","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts","volume":"62","author":"Vasen HF","year":"2013","journal-title":"Gut"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmg.2007.048991","article-title":"Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)","volume":"44","author":"Vasen HFA","year":"2007","journal-title":"J Med Genet"}],"container-title":["Revista de Sa\u00fade P\u00fablica"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsp\/v49\/0034-8910-rsp-S0034-89102015049005988.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T05:04:39Z","timestamp":1495515879000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0034-89102015000100603&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":9,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2015]]}},"alternative-id":["S0034-89102015000100603"],"URL":"https:\/\/doi.org\/10.1590\/s0034-8910.2015049005988","relation":{},"ISSN":["0034-8910"],"issn-type":[{"value":"0034-8910","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}